[{"AccountsPayableCurrent_0_Q1_USD":13086000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":66000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":792000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_1_Q1_USD":167726000.0,"AccretionExpense_1_Q1_USD":1761000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-7670000.0,"MarketableSecuritiesCurrent_0_Q1_USD":148126000.0,"ProceedsFromMinorityShareholders_1_Q1_USD":24094000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2797000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5647000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":8063000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":10222000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":734000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":42500000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":23210000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-103610000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q1_USD":0.0,"TreasuryStockValue_0_Q1_USD":75000000.0,"TreasuryStockShares_0_Q1_shares":2414681.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":472000.0,"StockRepurchasedDuringPeriodValue_1_Q1_USD":75000000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":734000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-91850000.0,"InvestmentIncomeInterest_1_Q1_USD":1941000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":841525000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":842251000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":757473000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":393276000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":9395000.0,"RestrictedCash_0_Q1_USD":424000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-1034000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.062,"OperatingLeaseRightOfUseAsset_0_Q1_USD":8855000.0,"OperatingLeasePayments_1_Q1_USD":700000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":8678000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2510000.0,"OperatingLeaseLiability_0_Q1_USD":11188000.0,"OperatingLeaseCost_1_Q1_USD":694000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_1_Q1_USD":26565000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-12232000.0,"NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_1_Q1_USD":-11366000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":2285000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2340000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2724000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1902000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1485000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1224000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":3798000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":13473000.0,"LeaseCost_1_Q1_USD":853000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":15000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":664000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q1_USD":-574000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-91378000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":986746000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":529000.0,"StockholdersEquity_0_Q1_USD":380715000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-531881000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":15755000.0,"ProfitLoss_1_Q1_USD":-104082000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":19782000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4477000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-83920000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":38023000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":439173000.0,"LiabilitiesCurrent_0_Q1_USD":64914000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":989799000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":117803438.0,"Liabilities_0_Q1_USD":537728000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":4234000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":34262000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.78,"CommonStockValue_0_Q1_USD":124000.0,"CommonStockSharesOutstanding_0_Q1_shares":121359855.0,"CommonStockSharesIssued_0_Q1_shares":123774536.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":757049000.0,"AssetsCurrent_0_Q1_USD":924957000.0,"Assets_0_Q1_USD":989799000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":23130938.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":726000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2846000.0,"TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0_Q1_USD":3053000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":7465000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":12375000.0,"OtherAssetsNoncurrent_0_Q1_USD":17022000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1595000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-12232000.0,"MinorityInterest_0_Q1_USD":68303000.0,"LongTermDebtNoncurrent_0_Q1_USD":92416000.0,"EmployeeBenefitsAndShareBasedCompensation_1_Q1_USD":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":449018000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":474000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":3145000.0,"ShareBasedCompensation_1_Q1_USD":10222000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ResearchAndDevelopmentExpense_1_Q1_USD":68225000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":25000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":75000000.0,"OperatingIncomeLoss_1_Q1_USD":-102487000.0,"OperatingExpenses_1_Q1_USD":102487000.0,"InterestPaidNet_1_Q1_USD":2054000.0,"InterestExpense_1_Q1_USD":4010000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":550000000.0,"VariableLeaseCost_1_Q1_USD":159000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200514"}]